-
Gan Lai Pharmaceutical's THRβ agonist phase I clinical trial in the United States achieved good top-line data
Time of Update: 2021-09-11
On September 8th, Gan Lai Pharmaceutical, a wholly-owned subsidiary of Gerry Pharmaceuticals, announced that the liver-targeted prodrug ASC41 oral tablet healthy subjects drug interactions and the pharmacokinetics of non-alcoholic fatty liver disease (NAFLD) patients PK (Phase I clinical trials in the United States) achieved good top-line data .
-
Nearly 1 billion people have been vaccinated nationwide with the new coronavirus vaccine
Time of Update: 2021-09-11
Wu Liangyou, deputy director of the National Health Commission's Disease Control Bureau, introduced that the overall vaccination of people aged 12-17 in China is progressing smoothly, and 162.
-
"Science": New crown virus traceability should pay attention to the possibility of cold chain transmission
Time of Update: 2021-09-11
The article said that the African swine fever epidemic in 2019 caused a shortage of pork products in China.
Large-scale demand has promoted the cold chain supply of all meat varieties, which may transport SARS-like coronavirus-susceptible animals .
-
Horizon Therapeutics' thyroid eye disease drug Tepezza enters Phase 4 clinical trials
Time of Update: 2021-09-11
Horizon Therapeutics recently announced that a Phase 4 clinical trial (NCT04583735) evaluating the efficacy and safety of Tepezza (teprotumumab) in the treatment of chronic (inactive) thyroid eye disease (TED) has enrolled the first patient .
-
Oxbryta Sickle Cell Disease Pediatric Indications & Dispersible Tablets Received Priority Review by the U.S. FDA
Time of Update: 2021-09-11
At the European Hematology Association (EHA) 2021 online meeting, a data analysis of 45 SCD children aged 4 to 11 years old showed that Oxbryta dispersible tablets (the subject of NDA) were used for weight-based treatment After that, hemoglobin continued to improve rapidly, and hemolysis (or red blood cell destruction) was also reduced .
-
National Health Commission: The introduction of restrictive measures violates the principle of vaccination
Time of Update: 2021-09-11
Wu Liangyou stated that the new crown virus vaccination should be carried out in accordance with the principles of informed, consent, voluntariness and seeking truth from facts, and emphasized that when introducing vaccination policies and measures, we must be rigorous and carefully evaluated to ensure compliance with laws and regulations and strictly adhere to the bottom line of safety .
-
Zhong Nanshan, Academician of the Chinese Academy of Engineering-Great doctors love to protect lives
Time of Update: 2021-09-11
Zhong Nanshan, Academician of the Chinese Academy of Engineering-Great doctors love to protect lives Zhong Nanshan, Academician of the Chinese Academy of Engineering-Great doctors l
-
Small interference nucleic acid therapy opens a new path for long-term lipid-lowering
Time of Update: 2021-09-11
"Professor Huo Yong from Peking University First Hospital said: Experts at the meeting believed that although the current statin therapy is effective in reducing LDL-C, the Chinese population using high-dose statins is more likely to have the risk of drug-induced myopathy and increased liver enzymes than other ethnic groups, so most Chinese people can only receive medium-dose statin treatment, and poor treatment compliance has further led to a low rate of compliance with statin treatment in patients .
-
Many governments and scholars voice their opposition to the politicization of the source of the new crown
Time of Update: 2021-09-11
On September 8, local time, the Ministry of Foreign Affairs of Sri Lanka issued the "Statement on the Traceability of the New Coronavirus", opposing the politicization of the traceability of the virus and demanding respect for the authority of the World Health Organization's joint research reports .
-
Medical insurance ushered in a heavy policy, and the era of strictest supervision is coming!
Time of Update: 2021-09-11
02Equipped with professional auditors In terms of audit staff, Article 6 of the Interim Measures states that handling agencies should strengthen the construction of medical security auditing capabilities, allocate staff, and hire relevant agencies and professionals to assist in inspections according to work needs; qualified provincial, municipal, and county medical services The security department may set up an independent medical security audit institution to undertake the medical security audit work .
-
Delta strain infections have been reported in 174 countries and regions
Time of Update: 2021-09-11
47 million new confirmed cases of new coronary pneumonia worldwide, except for the number of new cases in the Americas.
Increased, and the number of new cases in other regions decreased .
-
HER2 ADC innovation wave!
Time of Update: 2021-09-11
In January 2020, T-DM1 was approved for marketing by NMPA, and its indication is adjuvant for patients with HER2-positive early breast cancer who still have aggressive lesions after receiving neoadjuvant therapy based on taxanes combined with trastuzumab Treatment .
-
The first generic carfilzomib for injection of Hausen Pharmaceuticals was approved for only two months after the original research report
Time of Update: 2021-09-11
From: CDE official websiteCarfilzomib (carfilzomib) is a proteasome inhibitor, approved by the FDA on July 20, 2012, for patients with multiple myeloma who have received at least two previous types (bortezomib and immunomodulators).
-
Cinda Biotech declares that the first domestic SIRPα antibody CD47 pathway has deployed 3 new drugs
Time of Update: 2021-09-11
Author: Plus OneOn September 8, Cinda Biotech declared a new type of anti-SIRP-alpha antibody IBI397 (Alector R&D code: AL008) .
Domestic CD47 antibody drug development pattern (Insight)Cinda has already deployed 3 products for CD47-SIRPα, including CD47 monoclonal antibody IBI188 (letaplimab) and PD-L1/CD47 double antibody IBI322.
-
Knowing about the stability of pharmaceutical packaging materials
Time of Update: 2021-09-11
Research on the stability of pharmaceutical packaging materials is generally carried out by pharmaceutical packaging material manufacturers to confirm the quality stability period of their products under specified storage conditions.
-
Zai Lab exceeds USD 360 million to introduce multi-target inhibitors to apply for clinical application in China
Time of Update: 2021-09-11
Public information shows that Zai Lab announced in January 2021 that it will further deepen its strategic cooperation with Turning Point Therapeutics, and will obtain the latter's exclusive development and commercialization rights for TPX-0022 in Greater China .
-
New use of old medicine!
Time of Update: 2021-09-11
Article source: Medical Rubik's Cube InfoAuthor: SunshineOn September 7, Servier and Neurochlore announced that in two phase III clinical studies evaluating bumetanide and placebo in the treatment of autism spectrum disorder (ASD) in children and adolescents, no difference in efficacy was observed .
-
Wu Ziliang: Walking slowly and steady is science
Time of Update: 2021-09-11
Wu Ziliang: Walking slowly and steady is science Wu Ziliang: Walking slowly and steady is the science Wu Ziliang: Walking slowly and steady is the science Intern reporter Sun Min
-
Youhe Medicine's CD40 in the treatment of advanced solid tumors in China completed the first patient medication in the Phase I clinical study
Time of Update: 2021-09-11
This clinical study aims to evaluate the safety, tolerability and pharmacokinetics of YH003 in subjects with advanced solid tumors .
This study is a multi-center, open-ended, phase I dose escalation study evaluating the safety, tolerability and pharmacokinetics of YH003 in patients with advanced solid tumors .
-
The heavy rain caused the production of Atractylodes macrocephala to decrease, and the contradiction between supply and demand has not been reversed!
Time of Update: 2021-09-11
The price of the disaster-affected in the early period has risen Anguo Market: Affected by the rainfall in the Anhui production area, the number of Atractylodes macrocephala seeking goods in the market increased, and prices continued to rise .